Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast as Adjunct Treatment in Children With Atopic Dermatitis
NCT02534467Phase 4Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jul 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast in atopic dermatitis (AD), sponsored by Murdoch Children's Research Institute. Started Jul 2015; status: completed.
02
Drugs
montelukast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02534467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02534467.